Jordan Julie sold NGNE

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001968554-26-000005

Machine-readable

Structured copy

Timestamps

Event (reported)

Mar 26, 2026

Published

Mar 30, 2026

Ingested by INSIDER

Nov 5, 04:08 UTC

Last re-read

Nov 5, 04:08 UTC

Extracted facts

Filer

Jordan Julie

Role

Chief Medical Officer

Transaction

Open-market saleAs filed: “S”

Asset

Neurogene Inc.

Ticker

NGNE

Shares

828

Price per share

$21.89

Value

$18,128

Execution date (reported)

Mar 26, 2026

Owned after transaction

12.5K shares

Rule 10b5-1 plan

Yes, as checked by the filer

Days from execution to publication

4

Calculation

What this establishes

Jordan Julie filed this Form 4 reporting a open-market sale of NGNE on Mar 26, 2026. It became public on Mar 30, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Medical Officer

Jordan Juliecik:0001968554

Issuer

Neurogene Inc.cik:0001404644

Revision history · 0

No field has changed since this record was first ingested.